#1 Clinical Trials Search in Europe

Clobetasol Propionate

Clobetasol Propionate is a potent topical corticosteroid that has been the subject of several clinical trials for treating various skin conditions. This article explores the use of Clobetasol Propionate in clinical trials for conditions such as plaque psoriasis, oral lichen planus, bullous pemphigoid, and post-cataract surgery inflammation. We’ll discuss its efficacy, safety, and different formulations being tested to improve patient outcomes.

Table of Contents

What is Clobetasol Propionate?

Clobetasol propionate is a potent topical corticosteroid medication used to treat various skin conditions. It belongs to a class of drugs known as super-potent topical steroids, which means it is one of the strongest steroid medications that can be applied to the skin[1]. Clobetasol propionate is available under several brand names, including Clobex[2] and Olux[2].

What Conditions Does Clobetasol Propionate Treat?

Clobetasol propionate is used to treat a variety of skin conditions, including:

  • Plaque Psoriasis: A chronic autoimmune condition that causes rapid skin cell growth, resulting in thick, scaly patches on the skin[1][3]
  • Oral Lichen Planus: A chronic inflammatory condition affecting the mucous membranes of the mouth[4]
  • Bullous Pemphigoid: A rare autoimmune blistering disorder that primarily affects older adults[5]
  • Hand Dermatitis: A type of eczema that affects the hands[6]

Available Formulations

Clobetasol propionate is available in various formulations to suit different needs and treatment areas. These include:

  • Spray[2]
  • Foam[2]
  • Cream[3]
  • Ointment[1]
  • Lotion[7]
  • Ophthalmic nanoemulsion (for eye-related conditions)[8]
  • Patches (for oral conditions)[4]

How Does Clobetasol Propionate Work?

Clobetasol propionate works by reducing inflammation, itching, and redness in the affected areas of the skin. It achieves this by suppressing the immune system’s response in the skin, which helps to control the overactive immune reactions that cause many skin conditions[1]. In conditions like psoriasis, it also helps to slow down the rapid growth of skin cells that leads to the formation of plaques[3].

How is Clobetasol Propionate Administered?

The administration of clobetasol propionate varies depending on the formulation and the condition being treated. Generally, it is applied topically (directly to the skin) in a thin layer over the affected area. The frequency of application can range from once to twice daily, typically for a limited period of time as prescribed by a healthcare provider[1][3].

For oral conditions like oral lichen planus, special patches containing clobetasol propionate may be used. These patches are designed to adhere to the inside of the mouth and release the medication over time[4].

In some cases, such as for inflammation and pain after cataract surgery, clobetasol propionate may be formulated as an eye drop[8].

Efficacy of Clobetasol Propionate

Clobetasol propionate has been shown to be highly effective in treating various skin conditions. In clinical trials, it has demonstrated significant improvements in symptoms such as:

  • Reduction in psoriasis plaques and associated symptoms[3]
  • Improvement in hand dermatitis severity[6]
  • Reduction in inflammation and pain after cataract surgery[8]
  • Improvement in oral lichen planus symptoms[4]

The effectiveness of clobetasol propionate is often measured using scales such as the Investigator’s Static Global Assessment (ISGA), Psoriasis Area and Severity Index (PASI), and various symptom severity scores[3].

Safety and Side Effects

While clobetasol propionate is generally considered safe when used as directed, it can cause side effects, particularly with prolonged use or when applied to large areas of skin. Potential side effects may include:

  • Skin thinning or atrophy
  • Stretch marks
  • Increased risk of skin infections
  • Changes in skin pigmentation
  • Burning or stinging sensation at the application site

Due to its potency, clobetasol propionate should be used under the guidance of a healthcare provider. They will monitor for any adverse effects and adjust the treatment as necessary[3][1].

Ongoing Research

Researchers continue to study clobetasol propionate to optimize its use and explore new applications. Some areas of ongoing research include:

  • Comparing different formulations (e.g., spray vs. foam) for efficacy and patient preference[2]
  • Investigating its use in combination with other medications, such as methotrexate for bullous pemphigoid[5]
  • Developing new delivery methods, such as patches for oral conditions[4]
  • Exploring its potential in treating inflammation after eye surgery[8]

These ongoing studies aim to improve treatment outcomes and patient quality of life across various skin and mucosal conditions.

Condition Formulation Key Findings
Post-cataract surgery inflammation Ophthalmic nanoemulsion 0.05% Being tested for efficacy in reducing inflammation and pain after cataract surgery
Plaque Psoriasis Spray, foam, cream Compared efficacy of different formulations; spray and foam showed promising results
Oral Lichen Planus Rivelin® patches Novel patch delivery system being tested for effectiveness in treating oral lesions
Bullous Pemphigoid Topical cream/ointment Tested in combination with methotrexate for potential improved efficacy and reduced side effects
Chronic Hand Dermatitis Foam Evaluated for safety, efficacy, and tolerability in treating chronic hand dermatitis

FAQ

  • What skin conditions is Clobetasol Propionate being tested for in clinical trials? Clobetasol Propionate is being tested in clinical trials for various skin conditions, including plaque psoriasis, oral lichen planus, bullous pemphigoid, and post-cataract surgery inflammation and pain.
  • What forms of Clobetasol Propionate are being studied? Different forms of Clobetasol Propionate are being studied in clinical trials, including sprays, foams, creams, ointments, and even specialized patches for oral use.
  • How is Clobetasol Propionate being used in eye-related clinical trials? Clobetasol Propionate is being tested as an ophthalmic nanoemulsion (0.05%) for treating inflammation and pain associated with cataract surgery.
  • What is the typical duration of treatment with Clobetasol Propionate in these trials? The duration of treatment varies depending on the condition being treated. For example, in psoriasis trials, treatment typically lasts 2-4 weeks, while in post-cataract surgery trials, it's used for 14 days.
  • Are there any new delivery methods being tested for Clobetasol Propionate? Yes, one trial is testing Rivelin® patches containing Clobetasol Propionate for the treatment of oral lichen planus, which is a new method of delivering the medication directly to affected areas in the mouth.

Ongoing Clinical Trials on Clobetasol Propionate

  • Study on Clobetasol, Mometasone, and Tacrolimus for Treating Vulvar Lichen Sclerosus in Children

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study on Early Treatment of Plaque Psoriasis with Bimekizumab and Clobetasol Propionate for Patients with Chronic Inflammation

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Study on Clobetasol Propionate and Prednisolone Acetate for Treating Eye Inflammation After Cataract Surgery in Children Aged 0-3 Years

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • A study to evaluate the effect of topical clobetasol propionate versus a placebo for the treatment of inflammatory hand osteoarthritis in adults.

    Not yet recruiting

    1 1 1
    Investigated drugs:
    France

  • Study on the Effect of Clobetasol Propionate on Bone Mineral Density in Patients with Bullous Pemphigoid

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    France

Glossary

  • Plaque Psoriasis: A common form of psoriasis characterized by raised, red patches covered with a silvery white buildup of dead skin cells, typically on the scalp, knees, elbows and lower back.
  • Oral Lichen Planus: A chronic inflammatory condition that affects mucous membranes inside the mouth, causing white, lacy patches or red, swollen tissues.
  • Bullous Pemphigoid: A rare autoimmune skin disorder that causes large, fluid-filled blisters on areas of skin that often flex, such as the lower abdomen, upper thighs, or armpits.
  • Cataract Surgery: A procedure to remove the lens of the eye and replace it with an artificial lens when it has become cloudy, causing vision problems.
  • Topical Corticosteroid: A type of steroid medication applied directly to the skin to reduce inflammation, itching, and other symptoms associated with various skin conditions.
  • Nanoemulsion: A mixture of two liquids in which very small droplets of one liquid are scattered throughout the other, used to improve the delivery of certain medications.
  • Body Surface Area (BSA): A measurement used to estimate the extent of skin involvement in conditions like psoriasis, usually expressed as a percentage of total body surface area affected.
  • Investigator Global Assessment (IGA): A standardized method used by researchers to evaluate the overall severity of a skin condition during clinical trials.
  • Psoriasis Area Severity Index (PASI): A tool used to measure the severity and extent of psoriasis, taking into account the degree of redness, thickness, and scaling of psoriatic plaques.
  • Dermatology Life Quality Index (DLQI): A questionnaire used to measure the impact of skin diseases on a patient's quality of life.

References

  1. https://clinicaltrials.gov/study/NCT00733954
  2. https://clinicaltrials.gov/study/NCT00436540
  3. https://clinicaltrials.gov/study/NCT05706870
  4. https://clinicaltrials.gov/study/NCT03592342
  5. https://clinicaltrials.gov/study/NCT02313870
  6. https://clinicaltrials.gov/study/NCT00828464
  7. https://clinicaltrials.gov/study/NCT00864500
  8. https://clinicaltrials.gov/study/NCT04246801